Risk-adjusted Screening for Prostate Cancer-Defining the Low-risk Group by Data from the PROBASE Trial.
Krilaviciute A, Kaaks R, Seibold P, de Vrieze M, Lakes J, Radtke JP, Kuczyk M, Harke NN, Debus J, Fink CA, Herkommer K, Gschwend JE, Meissner VH, Benner A, Kristiansen G, Hadaschik B, Arsov C, Schimmöller L, Antoch G, Giesel FL, Makowski M, Wacker F, Schlemmer HP, Becker N, Albers P.
Krilaviciute A, et al. Among authors: wacker f.
Eur Urol. 2024 Dec;86(6):493-500. doi: 10.1016/j.eururo.2024.04.030. Epub 2024 May 15.
Eur Urol. 2024.
PMID: 38749854
Free article.